ArticleFrontiers in oncology2024

Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis.

Danqing Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.